A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection
Phase 1
Completed
- Conditions
- PediatricBacterial Infections
- Interventions
- Drug: Amoxicillin potassium clavulanate (Augmentin ES-600)
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Kaizen Bioscience Co.
- Target Recruit Count
- 39
- Registration Number
- NCT05584683
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath